This program aims to accelerate biomanufacturing equipment and process innovation, digital transformation, next generation therapies, and commercial adoption all at once focused on accelerating innovation in the manufacture, testing, and release of RNA-containing modalities.
Amount: Unspecified
Due Date: 12/19/2025 (Solution Summaries); 02/27/2026 (Full Proposals)